In Vitro Fertilization Procedures with Embryo Transfer and Their Association with Thrombophilia, Thrombosis and Early Antithrombotic Treatments

Overview

Journal J Blood Med

Publisher Dove Medical Press

Specialty Hematology

Date 2020 Jul 2

PMID 32607036

Citations 4

Authors

Pierpaolo Di Micco

Vincenzo Russo

Daniela Mastroiacovo

Marijan Bosevski

Corrado Lodigiani

Affiliations

Soon will be listed here.

Abstract

In vitro fertilization (IVF) procedures have been frequently associated with antithrombotic treatments, in particular, to aspirin or low-molecular-weight heparin (LMWH). The rationale of this treatment is based on the increase of thrombotic risk occurring in this clinical context. Indeed, both prothrombotic changes of coagulation parameters specifically related to IVF procedures as well as the presence of potential thrombophilic alterations may concur to increase the risk in these women. Furthermore, the presence of thrombophilia has been suggested as a potential cause of recurrent IVF failures. Therefore, antithrombotic treatments have been historically planned to prevent thrombotic disorders during pharmacological ovarian stimulation and/or to increase a successful rate of pregnancy and live births after IVF with embryo transfer. However, up to date, the role of inherited and\or acquired thrombophilia is still debated as well as a univocal therapeutic approach is lacking in women with infertility. The administration of antithrombotic drugs differs in several studies and even the dosages of aspirin and\or low-molecular-weight heparin are different. This review focuses on underlining current evidence on the role of thrombophilia and thromboprophylaxis in women selected for IVF with embryo transfer.

Citing Articles

Risk assessment of patients with underlying health conditions who present for IVF treatment.

Papathanasiou A, Hindmarsh D, Searle B J Assist Reprod Genet. 2024; 41(12):3251-3259.

PMID: 39249603 PMC: 11707091. DOI: 10.1007/s10815-024-03249-9.

Update on the Pharmacological Actions of Enoxaparin in Nonsurgical Patients.

Imbalzano E, Orlando L, Dattilo G, De Fazio M, Camporese G, Russo V Medicina (Kaunas). 2024; 60(1).

PMID: 38256416 PMC: 11154512. DOI: 10.3390/medicina60010156.

Low-molecular-weight heparin in thrombophilic women receiving in vitro fertilization/intracytoplasmic sperm injection: A meta-analysis.

Chen J, Bie J, Jiang F, Wu Y, Pan Z, Meng Y Acta Obstet Gynecol Scand. 2023; 102(11):1431-1439.

PMID: 37475190 PMC: 10577622. DOI: 10.1111/aogs.14634.

Ovarian hyperstimulation syndrome as a cause of acute limb ischemia.

Williams P, Buckley C Proc (Bayl Univ Med Cent). 2022; 35(2):254-255.

PMID: 35261472 PMC: 8865322. DOI: 10.1080/08998280.2021.2002116.

Subarachnoid haemorrhage in pregnancy after fertilisation with egg donation: a case report and review of the literature.

Hughes N, Choudhury S, Liyanage S, Hussain M Ther Adv Reprod Health. 2021; 15:26334941211023542.

PMID: 34377992 PMC: 8327222. DOI: 10.1177/26334941211023542.

References

Danolic D, Kasum M, Puljiz M, Alvir I, Tomica D, Mamic I . THE RISK OF HYPERCOAGULABILITY IN OVARIAN HYPERSTIMULATION SYNDROME. Acta Clin Croat. 2015; 54(2):186-92. View

Siristatidis C, Dafopoulos K, El-Khayat W, Salamalekis G, Anifandis G, Vrantza T . Administration of prednisolone and low molecular weight heparin in patients with repeated implantation failures: a cohort study. Gynecol Endocrinol. 2017; 34(2):136-139. DOI: 10.1080/09513590.2017.1380182. View

Wallenburg H, Rotmans N . Prevention of recurrent idiopathic fetal growth retardation by low-dose aspirin and dipyridamole. Am J Obstet Gynecol. 1987; 157(5):1230-5. DOI: 10.1016/s0002-9378(87)80300-9. View

Vaquero E, Lazzarin N, Caserta D, Valensise H, Baldi M, Moscarini M . Diagnostic evaluation of women experiencing repeated in vitro fertilization failure. Eur J Obstet Gynecol Reprod Biol. 2005; 125(1):79-84. DOI: 10.1016/j.ejogrb.2005.08.001. View

Kumar P, Mahajan S . Preimplantation and postimplantation therapy for the treatment of reproductive failure. J Hum Reprod Sci. 2013; 6(2):88-92. PMC: 3778611. DOI: 10.4103/0974-1208.117165. View

Urman B, Ata B, Yakin K, Alatas C, Aksoy S, Mercan R . Luteal phase empirical low molecular weight heparin administration in patients with failed ICSI embryo transfer cycles: a randomized open-labeled pilot trial. Hum Reprod. 2009; 24(7):1640-7. DOI: 10.1093/humrep/dep086. View

Urman B, Mercan R, Alatas C, Balaban B, Isiklar A, Nuhoglu A . Low-dose aspirin does not increase implantation rates in patients undergoing intracytoplasmic sperm injection: a prospective randomized study. J Assist Reprod Genet. 2001; 17(10):586-90. PMC: 3455451. DOI: 10.1023/a:1026491426423. View

Qublan H, Eid S, Ababneh H, Amarin Z, Smadi A, Al-Khafaji F . Acquired and inherited thrombophilia: implication in recurrent IVF and embryo transfer failure. Hum Reprod. 2006; 21(10):2694-8. DOI: 10.1093/humrep/del203. View

Golan A, Ron-El R, Herman A, Soffer Y, Weinraub Z, Caspi E . Ovarian hyperstimulation syndrome: an update review. Obstet Gynecol Surv. 1989; 44(6):430-40. DOI: 10.1097/00006254-198906000-00004. View

10.

Grandone E, Villani M, Dentali F, Tiscia G, Colaizzo D, Cappucci F . Low-molecular -weight heparin in pregnancies after ART -a retrospective study-. Thromb Res. 2014; 134(2):336-9. DOI: 10.1016/j.thromres.2014.06.004. View

11.

Coulam C, Jeyendran R, Fishel L, Roussev R . Multiple thrombophilic gene mutations are risk factors for implantation failure. Reprod Biomed Online. 2006; 12(3):322-7. DOI: 10.1016/s1472-6483(10)61004-8. View

12.

Dentali F, Ageno W, Rezoagli E, Rancan E, Squizzato A, Middeldorp S . Low-dose aspirin for in vitro fertilization or intracytoplasmic sperm injection: a systematic review and a meta-analysis of the literature. J Thromb Haemost. 2012; 10(10):2075-85. DOI: 10.1111/j.1538-7836.2012.04886.x. View

13.

Pakkila M, Rasanen J, Heinonen S, Tinkanen H, Tuomivaara L, Makikallio K . Low-dose aspirin does not improve ovarian responsiveness or pregnancy rate in IVF and ICSI patients: a randomized, placebo-controlled double-blind study. Hum Reprod. 2005; 20(8):2211-4. DOI: 10.1093/humrep/dei020. View

14.

Delvigne A, Kostyla K, De Leener A, Lejeune B, Cantiniaux B, Bergmann P . Metabolic characteristics of women who developed ovarian hyperstimulation syndrome. Hum Reprod. 2002; 17(8):1994-6. DOI: 10.1093/humrep/17.8.1994. View

15.

Potdar N, Gelbaya T, Konje J, Nardo L . Adjunct low-molecular-weight heparin to improve live birth rate after recurrent implantation failure: a systematic review and meta-analysis. Hum Reprod Update. 2013; 19(6):674-84. DOI: 10.1093/humupd/dmt032. View

16.

Orquevaux P, Masseau A, Le Guern V, Gayet V, Vauthier D, Guettrot-Imbert G . Fertilization in 37 Women with Systemic Lupus Erythematosus or Antiphospholipid Syndrome: A Series of 97 Procedures. J Rheumatol. 2017; 44(5):613-618. DOI: 10.3899/jrheum.160462. View

17.

Grandone E, Colaizzo D, Vergura P, Cappucci F, Vecchione G, Lo Bue A . Age and homocysteine plasma levels are risk factors for thrombotic complications after ovarian stimulation. Hum Reprod. 2004; 19(8):1796-9. DOI: 10.1093/humrep/deh346. View

18.

Lok I, Yip S, Cheung L, Yin Leung P, Haines C . Adjuvant low-dose aspirin therapy in poor responders undergoing in vitro fertilization: a prospective, randomized, double-blind, placebo-controlled trial. Fertil Steril. 2004; 81(3):556-61. DOI: 10.1016/j.fertnstert.2003.07.033. View

19.

Fishman P, Sredni B, Meroni P, Rudniki C, Shoenfeld Y . Aspirin modulates interleukin-3 production: additional explanation for the preventive effects of aspirin in antiphospholipid antibody syndrome. J Rheumatol. 1995; 22(6):1086-90. View

20.

Henriksson P, Westerlund E, Wallen H, Brandt L, Hovatta O, Ekbom A . Incidence of pulmonary and venous thromboembolism in pregnancies after in vitro fertilisation: cross sectional study. BMJ. 2013; 346:e8632. PMC: 3546085. DOI: 10.1136/bmj.e8632. View